CDKN2A and cancer: We hypothesize that CDKN2A mutations may play a crucial role in tumorigenesis by regulating the cell cycle of tumors and highly expressed CDKN2A may contribute to the malignancy of HNSC by mediating certain cancer-promoting signaling pathways.